Price, capacity key areas as Pfizer files for license in India

A senior government official said there will be a negotiation on the price and availability after the vaccine is approved for use in India. This person pointed to the vaccine’s $20 price tag in the US and compared it with the $3-4 at which the AstraZeneca/Oxford vaccine being made locally by the Serum Institute of India will be available.

from Hindustan Times - india https://ift.tt/36OAaIR
via IFTTT